These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35887356)

  • 1. Proteome-Wide Differential Effects of Peritoneal Dialysis Fluid Properties in an In Vitro Human Endothelial Cell Model.
    Sacnun JM; Hoogenboom R; Eibensteiner F; Sobieszek IJ; Unterwurzacher M; Wagner A; Herzog R; Kratochwill K
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal Dialysis Fluid Supplementation with Alanyl-Glutamine Attenuates Conventional Dialysis Fluid-Mediated Endothelial Cell Injury by Restoring Perturbed Cytoprotective Responses.
    Herzog R; Bartosova M; Tarantino S; Wagner A; Unterwurzacher M; Sacnun JM; Lichtenauer AM; Kuster L; Schaefer B; Alper SL; Aufricht C; Schmitt CP; Kratochwill K
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33334074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.
    Vychytil A; Herzog R; Probst P; Ribitsch W; Lhotta K; Machold-Fabrizii V; Wiesholzer M; Kaufmann M; Salmhofer H; Windpessl M; Rosenkranz AR; Oberbauer R; König F; Kratochwill K; Aufricht C
    Kidney Int; 2018 Dec; 94(6):1227-1237. PubMed ID: 30360960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Peritoneal Surface Proteome in a Model of Chronic Peritoneal Dialysis Reveals Mechanisms of Membrane Damage and Preservation.
    Boehm M; Herzog R; Klinglmüller F; Lichtenauer AM; Wagner A; Unterwurzacher M; Beelen RHJ; Alper SL; Aufricht C; Kratochwill K
    Front Physiol; 2019; 10():472. PubMed ID: 31156443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD membrane: biological responses to different PD fluids.
    Jörres A; Witowski J
    Contrib Nephrol; 2006; 150():48-53. PubMed ID: 16720991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alanyl-glutamine dipeptide restores the cytoprotective stress proteome of mesothelial cells exposed to peritoneal dialysis fluids.
    Kratochwill K; Boehm M; Herzog R; Lichtenauer AM; Salzer E; Lechner M; Kuster L; Bergmeister K; Rizzi A; Mayer B; Aufricht C
    Nephrol Dial Transplant; 2012 Mar; 27(3):937-46. PubMed ID: 21856758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there such a thing as biocompatible peritoneal dialysis fluid?
    Schmitt CP; Aufricht C
    Pediatr Nephrol; 2017 Oct; 32(10):1835-1843. PubMed ID: 27722783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid.
    Bartosova M; Herzog R; Ridinger D; Levai E; Jenei H; Zhang C; González Mateo GT; Marinovic I; Hackert T; Bestvater F; Hausmann M; López Cabrera M; Kratochwill K; Zarogiannis SG; Schmitt CP
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32823646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis.
    Linden T; Cohen A; Deppisch R; Kjellstrand P; Wieslander A
    Kidney Int; 2002 Aug; 62(2):697-703. PubMed ID: 12110035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-omics comparison of stress responses in mesothelial cells exposed to heat- versus filter-sterilized peritoneal dialysis fluids.
    Kratochwill K; Bender TO; Lichtenauer AM; Herzog R; Tarantino S; Bialas K; Jörres A; Aufricht C
    Biomed Res Int; 2015; 2015():628158. PubMed ID: 26495307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid.
    Herzog R; Kuster L; Becker J; Gluexam T; Pils D; Spittler A; Bhasin MK; Alper SL; Vychytil A; Aufricht C; Kratochwill K
    Sci Rep; 2017 Jul; 7(1):6229. PubMed ID: 28740213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose degradation products in peritoneal dialysis fluids: how they can be avoided.
    Wieslander A; Linden T; Kjellstrand P
    Perit Dial Int; 2001; 21 Suppl 3():S119-24. PubMed ID: 11887805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses - A First-In-Man Trial.
    Kratochwill K; Boehm M; Herzog R; Gruber K; Lichtenauer AM; Kuster L; Csaicsich D; Gleiss A; Alper SL; Aufricht C; Vychytil A
    PLoS One; 2016; 11(10):e0165045. PubMed ID: 27768727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and physiological relevance of glucose degradation products in peritoneal dialysis.
    Mittelmaier S; Niwa T; Pischetsrieder M
    J Ren Nutr; 2012 Jan; 22(1):181-5. PubMed ID: 22200439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal injury by methylglyoxal in peritoneal dialysis.
    Hirahara I; Kusano E; Yanagiba S; Miyata Y; Ando Y; Muto S; Asano Y
    Perit Dial Int; 2006; 26(3):380-92. PubMed ID: 16722033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studying the effects of new peritoneal dialysis solutions on the peritoneum.
    Chan TM; Yung S
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S87-93. PubMed ID: 17556337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge.
    Bonomini M; Masola V; Monaco MP; Sirolli V; Di Liberato L; Prosdocimi T; Arduini A
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress.
    Roumeliotis S; Dounousi E; Salmas M; Eleftheriadis T; Liakopoulos V
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32423139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.